Back to Search
Start Over
[Delirium in the "young" covid-19 patient (<65 years): preliminary clinical indications].
- Source :
-
Rivista di psichiatria [Riv Psichiatr] 2021 Jan-Feb; Vol. 56 (2), pp. 85-92. - Publication Year :
- 2021
-
Abstract
- Delirium is a phenomenon classified within neuro-cognitive disorders in the DSM-5. It has several etiologies and it is often lethal. This contribute aims at analyzing clinical characteristics and diagnostic possibilities of delirium in patients affected by covid-19. Furthermore, some preliminary recommendations on the use of psychopharmacological treatment of delirium and their interactions with main drugs used to treat covid-19 are given, with a special attention to comorbidities like in immunocompromised patients, in those affected by diabetes and cancer, in pregnant women or in addicted clients.
Details
- Language :
- Italian
- ISSN :
- 2038-2502
- Volume :
- 56
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Rivista di psichiatria
- Publication Type :
- Academic Journal
- Accession number :
- 33899829
- Full Text :
- https://doi.org/10.1708/3594.35766